bioAffinity Technologies, Inc. (BIAF) Operating cash flow 2021–2025
bioAffinity Technologies, Inc. (BIAF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.3MFY2025 · since FY2021: -$2.0M → -$9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.3M | -28.4% |
| FY2024 | -$7.3M | -20.3% |
| FY2023 | -$6.0M | -48.3% |
| FY2022 | -$4.1M | -98.7% |
| FY2021 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice